Cellus Group
Chile - International Distribution
CELLUS GROUP
CELLUS Group is a clinical-stage biomedical holding, focused on the development and commercialization of innovative cell therapies in the field of personalized medicine. Our mission is to fundamentally improve the treatment of invalidating diseases and injuries with unmet clinical needs, such as severe musculoskeletal damage and cancer.
CELLUS cell therapies are designed to restore the body’s native functions in a way that’s not possible with current traditional medicines. Our company developed an innovative and cost-effective cell purification and expansion method, to rapidly obtain large amounts of adult autologous clinical grade stem cells that are used to generate innovative cell products to heal musculoskeletal injuries faster and better. CELLUS also holds the exclusive licence of TapCells®, a personalized cellular immunotherapy for skin melanoma and prostate adenocarcinoma.
CELLUS Group comprehend CELLUS BIOMEDICA® as the holding company, where R&D, Quality Assurance System and IP is generated. CELLUS Group also incorporates three strategic divisions; CELLUS BIOFACTORY® (Advanced cellular products manufacturing), ONCOCELLUS® (Cancer Cellular Immunotherapy) and CELLUS CLINIC® (Regenerative rehabilitation and personalized cell
As researchers and problem solvers ourselves, we understand the value of sound data. We are proud to be a part of research that can better the world. We value the relationships, partnerships, and friendships that we have built with the people who trust and use our technology. We are committed to building these relationships. You can count on us to answer the phone and take time to thoroughly address questions or concerns about any of our products. In an industry that is reputed for grandiose claims, we trust that our quality standards and our customer service set us apart from the competition. If you’re happy with our products or if you think we can do something better, we hope you will let us know.